Skip to main content
logo
CHO Pharma, Inc. (TPEX:6586)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
119.00
+1.00 (0.85%)
Aug 6, 2026, 9:58 AM CST

CHO Pharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
25,2536,01411,02214,83025,20415,354
Market Cap Growth
204.12%-45.44%-25.68%-41.16%64.15%235.65%
Enterprise Value
23,2083,8098,56813,94424,03313,969
Last Close Price
118.0028.1051.5069.30137.0083.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
17647.274202.443078.64-420067.124300.98
PB Ratio
10.252.444.014.9917.648.80
P/TBV Ratio
12.362.944.745.8327.0612.44

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-2661.502393.25-400545.333912.99

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.01-0.010.02
Net Debt / Equity Ratio
-0.83-0.83-0.85-0.87-0.72-0.74
Net Debt / EBITDA Ratio
6.536.539.8310.403.186.99
Net Debt / FCF Ratio
7.087.0810.498.883.996.59
Asset Turnover
0.000.000.00-00.00
Quick Ratio
18.9618.9620.4124.576.199.89
Current Ratio
19.4719.4720.8124.936.3910.06
Return on Equity (ROE)
-11.13%-11.13%-7.41%-13.90%-21.33%-11.11%
Return on Assets (ROA)
-7.47%-7.47%-5.22%-7.17%-12.55%-6.52%
Return on Capital Employed (ROCE)
-13.20%-13.20%-9.00%-9.00%-24.50%-12.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.15%-4.82%-1.93%-2.06%-1.34%-1.34%
FCF Yield
-1.14%-4.80%-2.02%-1.98%-1.03%-1.28%
Buyback Yield / Dilution
---11.86%-4.00%-0.04%-0.12%